Sirolimus: A new agent for clinical renal transplantation
- 1 February 1997
- journal article
- review article
- Published by Elsevier in Transplantation Proceedings
- Vol. 29 (1-2), 48-50
- https://doi.org/10.1016/s0041-1345(96)00008-5
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- The Synergistic Effects Of Cyclosporine, Sirolimus, And Brequinar On Heart Allograft Survival In MiceTransplantation, 1995
- SYNERGISTIC IMMUNOSUPPRESSIVE ACTIONS OF CYCLOSPORINE WITH A MOUSE ANTI-RAT α/β-T CELL RECEPTOR MONOCLONAL ANTIBODYTransplantation, 1994
- Rapamycin: A novel immunosuppressive macrolideMedicinal Research Reviews, 1994
- EFFECTS OF RAPAMYCIN IN EXPERIMENTAL ORGAN ALLOGRAFTINGTransplantation, 1993
- THE SYNERGISTIC INTERACTIONS IN VITRO AND IN VIVO OF BREQUINAR SODIUM WITH CYCLOSPORINE OR RAPAMYCIN ALONE AND IN TRIPLE COMBINATIONTransplantation, 1993
- Effects of rapamycin on human HLA-unrestricted cell killingClinical Immunology and Immunopathology, 1992
- IN VITRO CORRELATES OF IN VIVO THERAPY WITH CYCLOSPORINE TO IMMUNOSUPPRESS REJECTION OF HETEROTOPIC RAT CARDIAC ALLOGRAFTS ACROSS STRONG (RT-1) PLUS WEAK (NON-RT-1) HISTOCOMPATIBILITY DIFFERENCESTransplantation, 1991
- Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexesCell, 1991
- PRECLINICAL EVALUATION OF A NEW POTENT IMMUNOSUPPRESSIVE AGENT, RAPAMYCINTransplantation, 1991
- RAPAMYCIN FOR IMMUNOSUPPRESSION IN ORGAN ALLOGRAFTINGThe Lancet, 1989